Lifecore Biomedical, Inc. / Fundamentals
Income statement
- Net revenue
€111.03M - Cost of goods sold
€76.31M - Gross profit
€34.72M - SG&A expenses
€37.95M - R&D expenses
€7.11M - EBITDA
-€33.36M - D&A
€0.00 - EBIT
-€33.36M - Interest expenses
-€2.55M - EBT
-€33.32M - Tax expenses
-€37.05K - Net income
-€33.36M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€7.80M - Changes in working capital
€0.00 - Operating cash flow
-€177.48K - Capex
€11.56M - Other investing cash flow
€6.03M - Net investing cash flow
-€5.53M - Total cash dividends paid
-€4.19M - Issuance of common stock
€20.55M - Debt repayment
€0.00 - Other financing cash flow
-€16.78M - Net financing cash flow
€5.53M - Foreign exchange effects
€0.00 - Net change in cash
€17.91M - Cash at end of period
€7.12M - Free cash flow
€11.38M
Balance sheet
- Cash and cash equivalents
€7.12M - Cash and short-term investments
€7.12M - Total receivables
€19.95M - Inventory
€27.82M - Other current assets
€18.93M - Total current assets
€73.81M - Property, plant & equipment
€111.14M - Goodwill
€11.96M - Intangible assets
€3.62M - Long-term investments
€0.00 - Other non-current assets
€5.67M - Total non-current assets
€132.39M - Total assets
€206.20M - Accounts payable
€7.08M - Short-term debt
€0.00 - Other current liabilities
€18.92M - Total current liabilities
€26.00M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€139.34M - Total non-current liabilities
€139.34M - Total liabilities
€165.34M - Common stock
€31.88K - Retained earnings
-€176.82M - Other equity
€0.00 - Total equity
€1.15M - Total liabilities and shareholders' equity
€166.49M
Company information
- Market capitalization
€258.65M - Employees
524 - Enterprise Value
€375.22M
Company ratios
- Gross margin
-
31.3% Much worse than peer group: 65.7% - EBITDA margin
-
-30.0% Much better than peer group: -155.4% - EBIT margin
-
-30.0% Much better than peer group: -138.5% - EBT margin
-
-30.0% Much better than peer group: -170.2% - Net margin
-
-30.0% Much better than peer group: -170.1% - ROE
-
-2,898.0% Even with peer group: -2,894.4% - ROA
-
-16.2% Even with peer group: -14.4% - Asset turnover
-
53.8% Better than peer group: 41.8% - FCF margin
-
-10.6% Much better than peer group: -116.2% - FCF yield
-4.5% - Efficiency ratio
130.0% - Net sales per employee
-
€211.88K - Net income per employee
-
-€63.66K